HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combined intravitreal bevacizumab and triamcinolone acetonide injection for idiopathic neuroretinitis.

AbstractPURPOSE:
To present a case with idiopathic neuroretinitis that was treated with combined intravitreal bevacizumab and triamcinolone.
DESIGN:
Case report.
METHODS:
Interventional case report.
RESULTS:
A 31-year-old man presented with a visual acuity of 3/10 and afferent pupillary defect in the right eye. Ophthalmologic examination disclosed papillitis and macular edema. Neurology consultation with cranial computerized tomography scan revealed no abnormality. The patient was injected with bevacizumab and triamcinolone intravitreally. One week later, the vision increased to 10/10, macular edema disappeared. One month later, optic disc edema disappeared.
CONCLUSIONS:
Intravitreal injection of bevacizumab and triamcinolone effectively treated idiopathic neuroretinitis.
AuthorsMehmet Cakir, Osman Cekiç, Ercüment Bozkurt, Gökhan Pekel, Ahmet T Yazici, Omer F Yilmaz
JournalOcular immunology and inflammation (Ocul Immunol Inflamm) 2009 May-Jun Vol. 17 Issue 3 Pg. 221-3 ISSN: 1744-5078 [Electronic] England
PMID19585368 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Glucocorticoids
  • Vascular Endothelial Growth Factor A
  • Bevacizumab
  • Triamcinolone Acetonide
Topics
  • Adult
  • Angiogenesis Inhibitors (therapeutic use)
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Drug Therapy, Combination
  • Fluorescein Angiography
  • Glucocorticoids (therapeutic use)
  • Humans
  • Injections
  • Male
  • Papilledema (drug therapy)
  • Retinitis (drug therapy)
  • Tomography, Optical Coherence
  • Triamcinolone Acetonide (therapeutic use)
  • Vascular Endothelial Growth Factor A (antagonists & inhibitors)
  • Visual Acuity
  • Vitreous Body

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: